loadpatents
Patent applications and USPTO patent grants for Hogaboam; Cory.The latest application filed is for "therapeutic antibodies and uses thereof".
Patent | Date |
---|---|
Method of predicting progression of idiopathic pulmonary fibrosis and monitoring of therapeutic efficacy Grant 11,397,178 - Hogaboam , et al. July 26, 2 | 2022-07-26 |
Therapeutic Antibodies And Uses Thereof App 20200255509 - Kind Code | 2020-08-13 |
Antibody targeting stem cell factor Grant 10,501,535 - Lukacs , et al. Dec | 2019-12-10 |
Method Of Predicting Progression Of Idiopathic Pulmonary Fibrosis And Monitoring Of Therapeutic Efficacy App 20190271689 - Hogaboam; Cory ;   et al. | 2019-09-05 |
Therapeutic Antibodies And Uses Thereof App 20160257742 - LUKACS; NICHOLAS W. ;   et al. | 2016-09-08 |
Therapeutic Antibodies And Uses Thereof App 20150018408 - Lukacs; Nicholas W. ;   et al. | 2015-01-15 |
Biomarkers Predictive Of Progression Of Fibrosis App 20120282276 - Hogaboam; Cory ;   et al. | 2012-11-08 |
NCAGE Code | 44P81 | HOGABOAM CORY |
CAGE Code | 44P81 | HOGABOAM CORY |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.